Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • vskomarovsky vskomarovsky Nov 4, 2012 11:24 AM Flag

    from Forbes

    There have been changes to the FDA. One of the most dramatic, as a result of a recently passed law, is that many more medicines should be approved on an “accelerated” basis, before results are in. Wall Street has woken up to this. Extremely positive results for a muscular dystrophy drug developed by Sarepta Therapeutics are being talked about as a reason the medicine might be approved.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SRPT
35.70-0.99(-2.70%)Aug 31 4:00 PMEDT